LIVE Stock Market Updates: Indian stock markets were trading marginal cuts Tuesday, though gains at Reliance Industries topped losses. The S&P BSE Sensex was hovering around 49,140, down 120 points, and the Nifty50 index was testing 14,500 levels. IndusInd Bank (down 2%) was Sensex’s top loser, followed by Kotak Mahindra …
Read More »India May Start Producing Russia’s Sputnik V COVID-19 Vaccine: Putin
Putin also proposed accelerating the creation of a vaccine research center for the BRICS countries (Brazil, Russia, India, China and South Africa), TASS reported. Russia’s Sputnik V vaccine is 92% effective in protecting people from COVID-19 based on the results of interim trials, the country’s sovereign wealth fund said on …
Read More »Dr Reddy’s isolates all data center services after a cyberattack
Dr Reddy’s Laboratories, a leading Indian pharmaceutical company, said today that it has isolated all data center services to take necessary preventive actions in the wake of a cyber attack. The company also added that it anticipates that all services will be active within 24 hours and “we do not …
Read More »Humanity signs a pact for the sale of Sputnik V in India
NEW DELHI The Russian Direct Investment Fund (RDIF) has signed a pact with Delhi-based pharmaceutical company Mankind Pharma for the marketing and distribution of its Sputnik V vaccine, two sources with knowledge of the matter said. “It depends on how many doses you give to humanity. RDIF has deals with …
Read More »Dr. Reddy’s Gets Clearance From DCGI to Conduct Phase 2/3 Human Trials of Sputnik V in India | India News
HYDERABAD: After India’s drug regulator rejected Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct phase 3 direct human trials for the Russian Covid-19 Sputnik V vaccine, the company and fund Russian investment sovereign Russian Direct Investment Fund (RDIF) have now received the go-ahead from Drug Control of India …
Read More »Setback for Russia when India rejects proposal to test Sputnik-V Covid-19 vaccine in large study
Recommendations from a panel of experts from the Central Standard Medicines Control Organization (CDSCO) noted that safety and immunogenicity data from early-stage studies conducted abroad are small and no information is available on the Indian participants. India’s move marks a setback for Russia’s plan to launch the vaccine even before …
Read More »India Rejects Proposal to Test Russia’s Sputnik-V Covid-19 Vaccine in Large Study
India’s drug regulator rejected a proposal from Dr Reddy’s Laboratories Ltd to conduct a large study in the country to evaluate Russia’s Sputnik-V COVID-19 vaccine and asked it to first test the vaccine in a smaller trial. Recommendations from a panel of experts from the Central Standard Medicines Control Organization …
Read More »Dr Reddy Requested to Re-apply for the Two Phase 2.3 Trials of the Russian COVID-19 Sputnik V Vaccine
New Delhi: A panel of experts from the Central Standard Medicines Control Organization (CDSCO) has requested Dr. Reddy’s Laboratories to submit a revised protocol for conducting phase 2 and phase 3 human clinical trials for the Russian COVID vaccine -19, Sputnik V, in India, sources said Monday. The Hyderabad-based pharmaceutical …
Read More »DGCI requests Dr. Reddy’s laboratory to review the protocol for testing the Russian Covid-19 Sputnik V vaccine
In the latest development, the expert panel of the Controller General of Medicines of India (DCGI) has directed the pharmaceutical giant Dr Reddy’s Laboratories (DRL) to submit a revised protocol to conduct phase 2.3 clinical trials of the Russian Covid vaccine. -19 (Sputnik V) in India, said a government official. …
Read More »RIL, Lakshmi Vilas Bank, Mindtree, Dr. Reddy’s, Sun Pharma, Ceat
NEW DELHI Here is a list of the top ten stocks that may appear in the news on Monday: Dependency Industries: Reliance Retail Ventures Limited, the retail business of Mukesh Ambani’s Reliance Industries Ltd (RIL), has received ₹Rs 7.5 billion from tech investor Silver Lake, the company said in a …
Read More »